RIGGS RORY B
SEC CIK 1016835 · EDGAR
BoughtSold
Most active insiders at CBUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Urban Thomas | Dir | — | — |
| 2 | Wichner Craig | CEO | — | — |
| 3 | Stokes Jason | CLO, Gen Csl, Secy | — | — |
| 4 | Sauer Noel | SVP, Research | — | — |
| 5 | Broos Carlo | CFO | — | — |
| 6 | Prante Gerhard | Dir | — | — |
| 7 | Lehmann Jean-Pierre Jules | Dir | — | — |
| 8 | Gocal Gregory Francis William | CSO, EVP | — | — |
| 9 | Beetham Peter | Pres, COO, Interim CEO, Dir | — | — |
| 10 | RIGGS RORY B | Dir, 10% | — | — |
Transactions 43
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | 2026-01-29 | CBUS | Cibus, Inc. | RIGGS RORY B | Dir, 10% | A - Grant | $1.50 | +333.3K | 14.92M | +2% | +$500.0K | |
| DM | 2025-06-11 | 2025-06-09 | CBUS | Cibus, Inc. | RIGGS RORY B | Dir, 10% | X - OptEx | $0.0001 | +4.05M | 14.58M | +38% | +$500 |
| 2025-06-10 | 2025-06-05 | CBUS | Cibus, Inc. | RIGGS RORY B | Dir, 10% | A - Grant | $1.75 | +5.71M | 10.53M | +119% | +$10.00M | |
| DM | 2025-01-10 | 2024-12-31 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | C - Cnv Deriv | — | 0 | 4.84M | New | — |
| 2024-09-20 | 2024-09-18 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | A - Grant | $4.00 | +250.0K | 3.45M | +8% | +$1.00M | |
| D | 2024-06-14 | 2024-06-11 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | A - Grant | $10.20 | +98.0K | 3.20M | +3% | +$1.00M |
| D | 2024-02-22 | 2024-02-20 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | C - Cnv Deriv | $0.00 | +300.0K | 320.1K | +1,493% | $0 |
| M | 2024-01-04 | 2024-01-02+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $28.14 | -470.0K | 254.9K | -65% | -$13.22M |
| D | 2024-01-03 | 2023-12-29 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | J - Other | $0.00 | +1.51M | 2.87M | +111% | $0 |
| DM | 2024-01-03 | 2023-12-29 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | C - Cnv Deriv | $0.00 | 0 | 1.37M | New | $0 |
| DI | 2023-12-14 | 2023-09-27 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | J - Other | $0.00 | -39.5K | 1.11M | -3% | $0 |
| D | 2023-12-14 | 2023-12-12 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | P - Purchase | $10.58 | +517.1K | 1.62M | +47% | +$5.47M |
| D | 2023-11-14 | 2023-11-13 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | C - Cnv Deriv | $0.00 | +475.6K | 490.1K | +3,278% | $0 |
| 2023-06-26 | 2023-06-23 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | A - Grant | $0.00 | +7,747 | 14.5K | +115% | $0 | |
| DM | 2023-06-02 | 2023-05-31 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | A - Grant | — | +2.38M | 848.7K | New | — |
| DMI | 2023-06-02 | 2023-05-31 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | A - Grant | — | +1.66M | 851.6K | New | — |
| D | 2023-06-02 | 2023-06-01 | CBUS | Cibus, Inc. | RIGGS RORY B | CEO, Dir, 10% | P - Purchase | $31.50 | +1,000 | 1.15M | +0.1% | +$31.5K |
| 2023-05-22 | 2023-05-22 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $32.82 | -1.75M | 6,762 | -100% | -$57.44M | |
| D | 2023-05-12 | 2023-05-09 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | C - Cnv Deriv | $0.00 | +300.0K | 1.76M | +21% | $0 |
| M | 2023-03-30 | 2023-03-29+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $36.31 | -139.9K | 1.59M | -8% | -$5.08M |
| D | 2023-02-17 | 2023-02-17 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | C - Cnv Deriv | $0.00 | +1.50M | 1.60M | +1,551% | $0 |
| M | 2022-12-13 | 2002-12-12+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $42.01 | -60.0K | 96.7K | -38% | -$2.52M |
| 2022-11-21 | 2022-11-17 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $42.33 | -120.0K | 156.7K | -43% | -$5.08M | |
| M | 2022-09-15 | 2022-09-14+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $42.31 | -100.0K | 328.7K | -23% | -$4.23M |
| 2022-08-11 | 2022-08-09 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $43.73 | -45.0K | 376.7K | -11% | -$1.97M | |
| 2022-06-29 | 2022-06-29 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $42.17 | -30.0K | 421.7K | -7% | -$1.27M | |
| M | 2022-05-23 | 2022-05-19+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $39.42 | -150.0K | 451.7K | -25% | -$5.91M |
| 2022-03-30 | 2022-03-29 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $38.59 | -60.0K | 601.7K | -9% | -$2.32M | |
| M | 2022-03-21 | 2022-03-17 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | +69.0K | 661.7K | +12% | — |
| MI | 2022-03-21 | 2022-03-17 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | -1.84M | 141.4K | -93% | — |
| MI | 2022-03-21 | 2022-03-18+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $39.43 | -169.1K | 0 | -100% | -$6.67M |
| M | 2021-12-30 | 2021-12-28 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | +45.4K | 667.7K | +7% | — |
| MI | 2021-12-30 | 2021-12-28 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | -1.27M | 708.2K | -64% | — |
| 2021-12-30 | 2021-12-29 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $40.00 | -75.0K | 592.7K | -11% | -$3.00M | |
| MI | 2021-12-30 | 2021-12-28 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $40.21 | -109.4K | 673.1K | -14% | -$4.40M |
| M | 2021-11-18 | 2021-11-16 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | +66.0K | 636.1K | +12% | — |
| M | 2021-11-18 | 2021-11-16+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $42.33 | -75.0K | 622.4K | -11% | -$3.17M |
| MI | 2021-11-18 | 2021-11-16 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | -1.86M | 1.15M | -62% | — |
| MI | 2021-11-18 | 2021-11-17 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $42.35 | -139.4K | 1.12M | -11% | -$5.90M |
| DM | 2021-09-30 | 2021-09-29 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | +16.3K | 631.4K | +3% | — |
| DMI | 2021-09-30 | 2021-09-29 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | J - Other | — | -936.4K | 789.5K | -54% | — |
| DMI | 2021-09-30 | 2021-09-29 | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $36.35 | -63.8K | 899.3K | -7% | -$2.32M |
| DM | 2021-09-30 | 2021-09-28+ | RPRX | Royalty Pharma plc | RIGGS RORY B | Dir | S - Sale | $36.65 | -64.6K | 615.1K | -10% | -$2.37M |
Purchase Sale Sale after option exercise All abbreviations